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Abstract
The encapsulation of proteins in biomimetic silica has recently been shown to successfully
maintain enzymes in their active state. Organophosphate (OP) compounds are employed as
pesticides as well as potent chemical warfare nerve agents. Because these toxicants are life
threatening, we sought to generate biomimetic silicas capable of responding to OPs. Here, we
present the silica encapsulation of human drug metabolism enzyme carboxylesterase 1 (hCE1) in
the presence of a range of catalysts. hCE1 was successfully encapsulated into silica particles when
lysozyme or the peptide R5 were used as catalysts; in contrast, polyethyleneimine (PEI), a catalyst
employed to encapuslate other enzymes, did not facilitate hCE1 entrapment. hCE1 silica particles
in a column chromatography format respond to the presence of the organophosphate (OP)
pesticides paraoxon and dimethyl-p-nitrophenyl phosphate in solution. These results may lead to
novel approaches to detect OP pesticides or other weaponized agents that bind hCE1.
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INTRODUCTION
Sol-gel and biomimetic reactions have facilitated the use of immobilized enzymes in a range
of applications1. For example, several recent studies have employed the biomineralization of
silica to encapsulate a variety of enzymes. This reaction occurs rapidly at room temperature
using tetramethylorthosilicate (TMOS) and a polycationic catalyst to promote silica
formation around the target enzyme. Proteins encapsulated using this approach can be used
to catalyze highly specific reactions, to screen for enzyme inhibitors, or to detect the
presence of chemical compounds. Indeed, silica particles containing enzymes have been
employed in biosensing applications, including microfluidic devices and aerosol
detectors2,3.
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There are several advantages to using silica particles for encapsulation, including the fact
that the mild reaction conditions promote the capture of active enzymes, and, in some cases,
increase enzyme stability4. The simplicity and speed of the reaction also allow for rapid
encapsulation and the cost-effective production of the particles for various needs. For
example, encapsulated enzymes could be used in a column format to monitor for chemical
contaminants in water sources. However, encapsulation efficiency varies with the catalyst-
enzyme pair5. Thus, optimal encapsulation conditions must be identified for each enzyme
before they can be applied in a useful setting.
One promising application of encapsulated protein is the detection of chemical compounds,
such as organophosphates (OP). OPs are employed as agricultural pesticides, but have also
been weaponized for use as highly toxic nerve agents like sarin, soman, and cyclosarin6,7.
OP toxicity arises from the noncompetitive inhibition of acetylcholinsterase (AChE), which
produces sustained acetylcholine stimulus of the muscarinic and nicotinic receptors and may
lead to diaphragm incapacitation resulting in suffocation. Biosensors containing enzymes
inhibited by OPs have recently been explored for military and civilian applications2,8,9.
The human liver carboxylesterase 1 (hCE1) is a promiscuous serine hydrolase that catalyzes
the hydrolysis of endogenous molecules and xenobiotics containing ester, amide, or thioester
bonds10,11,12,13,14,15,16,17. This structural AChE homolog is currently being explored as a
prophylactic bioscavenger to decontaminate OP toxicity18. Based upon the ability of hCE1
to bind Ops15,18, we sought to examine the silica encapsulation of hCE1 and the ability of
the resultant nanoparticles to detect the presence of OP toxicants.
MATERIALS AND METHODS
Expression and purification of hCE1
A secreted form of hCE1 was expressed using baculovirus infection of Spodptera frugiperda
Sf21 cells and purified as described19. hCE1 was concentrated in 50 mM HEPES (pH 7.4)
and stored at 4 °C. Protein concentration was determined spectrophotometrically using an
extinction coefficient 17700 M−1 cm−1 (NanoDrop, ND-1000 Spectrophotometer).
Preparation of silica nanoparticles with hCE1
All materials were purchased from Sigma-Aldrich unless otherwise noted. A stock solution
of lysozyme at 100 mg/ml was prepared in 0.1 M potassium phosphate buffer (pH 7.4). A
solution of hydrolyzed tetramethyl orthosilicate (TMOS) was freshly prepared by diluting
into 1 mM hydrochloric acid to a final concentration of 1 M. A typical reaction mixture
consisted of 800 μl of 0.1 M potassium phosphate buffer containing 5 μg of hCE1, 100 μl
of lysozyme or R5 solution (100 mg/ml), and 100 μl of 1 M hydrolyzed TMOS. The mixture
was incubated at room temperature (22 °C) for 10 minutes with gentle shaking. The slurry
was centrifuged for 60 s (13,000 rpm) to remove the particles and washed in ddH2O three
times. Control particles were produced in a similar manner using a reaction mixture without
hCE1 by combining 800 μl of 0.1 M potassium phosphate buffer, 100 μl of lysozyme
solution, and 100 μl of hydrolyzed TMOS. Combination particles were created using ratios
of polyethyleneimine (1%) to lysozyme (100 mg/mL) 1:4, 1:1, 4:1 as the catalyst to compare
the efficiency of enzyme incorporation. The total volume of catalyst used was always equal
to 10% of the silica reaction.
Scanning and transmission electron microscopy
The morphology of silica-encapsulated hCE1 with various catalyst was observed with a
Hitachi 4700 Scanning Electron Microscope (SEM) and a JEOL 2010F Transmission
Electron Microscope (TEM). SEM samples were prepared by depositing dry powdered
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samples on a double-stick carbon tape on an aluminium SEM sample holder. The samples
were coated with a 3nm Au-Pd conductive coating in order to prevent charging effect during
imaging. TEM samples were prepared by air-drying a drop of concentrated reaction mixture
on a carbon-stabilized copper grid (Ted Pella Inc.).
Determination of hCE1 enzyme activity
Activity of silica-encapsulated or solution hCE1 were monitored using para-nitrophenyl
butyrate (pNPB) as a substrate and measuring the absorbance of the para-nitrophenol
product at 410 nm using a Pherastar spectrophotometer (BMG Labtech). The substrate was
dissolved in ethanol to a concentration of 1 M, and then diluted to 10 mM in 0.1 M
phosphate buffer pH 7.4. hCE1 silica particles were mixed with substrate at a final
concentration of 5 mM. Supernatants from the washes were saved and monitored in the
same fashion to determine the incorporation efficiency of the silica reactions.
Kinetics of para-nitrophenyl butyrate hydrolysis
Km, Vmax, and kcat values were determined by monitoring the conversion of pNPB to para-
nitrophenol at 410 nm using a Pherastar spectrophotometer (BMG Labtech). Substrate was
prepared as described above. Data was collected over 4 minutes and the linear portions were
used for the linear regressions to calculate the reaction velocities. Kinetic parameters were
determined by plotting the reaction velocities versus substrate concentration. An extinction
coefficient of 17700 was used for para-nitrophenol in calculating the Vmax. The molecular
weight for hCE1 that was used to calculate the kcat was 61.68 kDa. The Prism software
packaged was used to fit the data (GraphPad, San Diego, CA).
Column-based experiments
Column activity of silica-encapsulated hCE1 was determined using a stainless steel
microbore column (2 cm × 2 mm, Upchurch Scientific, Oak Harbor, WA) with 0.5 μm frits.
The silica nanoparticle reaction mixture was scaled up to a total of 10 mL. The particles
were resuspended in 0.1 M phosphate buffer pH 7.4 and pumped at a flow rate of 10 μL/min
to pack the column. The column was washed with 10 column volumes of phosphate buffer
prior to use. All column experiments were performed at room temperature (22 °C) at a flow
rate of 100 μL/min using a NE-1000 syringe pump (New Era Pump Systems, Wantagh,
NY). Phosphate buffer containing 5 mM substrate was flowed through the column. Samples
were collected and analyzed in a Pherastar spectrophotometer to measure absorbance at 410
nm until the substrate hydrolysis had reached a maximum.
Organophosphate pesticide detection
Using a column constructed in the manner described above, phosphate buffer containing 5
mM substrate was applied and absorbance was measured until the substrate hydrolysis
reached its maximum value. Phosphate buffer containing 5 mM substrate and paraoxon or
DMPNPP (1mM) was then flowed through the column, and absorbance was measured at
410 nm to determine if OP was detected. A drop in absorbance at 410 nm correlates with
enzyme inhibition because the product of the enzyme assay, paranitrophenol, absorbs at 410
nm. The pesticides were diluted 1:10 in methanol and further diluted in 0.1 M phosphate
buffer pH 7.4 to their final concentration. Inhibition was confirmed by flowing phosphate
buffer containing 5 mM substrate through the column and monitoring absorbance at 410 nm.
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Silica Encapsulation of Active hCE1
Initial experiments employed lysozyme as the polycation catalyst for silica nanoparticle
formation in reaction conditions containing hydrolyzed tetramethylorthosilicate (TMOS),
lysozyme (100 mg/mL), and potassium phosphate buffer at pH 7.4 with 5 μg of hCE1
enzyme. hCE1 was incorporated into the particles with high efficiency, leaving no enzyme
activity in the supernatant (Figure 1A). In addition, no hCE1 activity was detected in
solutions used to wash the particles after formation (Figure 1A). Thus, while the process
may render some hCE1 inactive, all detectable enzyme activity localized solely to the
particles. hCE1 activity in the silica nanoparticles, as measured by para-nitrophenyl butyrate
(pNPB) hydrolysis, reached the same maximal velocity as 5 μg of hCE1 in solution;
however, the encapsulated enzyme exhibited a slightly reduced initial rate of product
formation (Figure 1A, Table I). Multiple washes of silica particles with phosphate buffer did
not release active enzyme, indicating that the hCE1 activity associated with the particles did
not arise from enzyme adhered relatively loosely to particle surfaces. Similarly, several
washes of particles in 1% Tween 20 did not dissociate hCE1 activity from the particles (data
not shown). When washed in detergent, the hCE1 activity in the particles was comparable to
the activity measured from particles washed in buffer alone (Table I).
We examined the effect of entrapping hCE1 in silica on the enzyme's ability to hydrolyze
pNPB. Kinetic experiments were performed maintaining a constant amount of enzyme with
varied substrate concentrations to determine initial reaction velocities. Michaelis-Menten
kinetics was assumed and the kinetic parameters were determined (Table II). hCE1 in silica
had a Km that was approximately three times higher than enzyme in solution. Furthermore,
hCE1 in silica exhibited a slightly reduced efficiency (kcat/Km = 3.1 × 104 s−1 M−1) relative
to free enzyme (kcat/Km = 1.9 × 104 s−1 M−1). These solution values are in agreement with
previously reported kinetic parameters for hCE1 with para-nitrophenyl butyrate (pNPB)20.
Taken together, these results demonstrate that active hCE1 can be efficiently incorporated
into lysozyme-catalyzed silica nanoparticles.
We also investigated the ability of other cationic catalysts to generate hCE1-encapsulated
silica nanoparticles. We created silica particles in the presence of hCE1using the following
catalysts: cationic peptide R5 (NH2-SSKKSGSYSGSKGSKRRIL-CO2H)21 and the polymer
polyethyleneimine (PEI). We found that silica particles formed with the R5 peptide
exhibited similar incorporation efficiency and enzyme activity as the lysozyme hCE1-silica
particles (Figure 1B, Table I). In contrast, PEI catalyzed particles, which formed
immediately upon mixing (compared to ~5 minutes with the lysozyme or R5 silica particles)
excluded hCE1 into the supernatant and thus had no associated enzyme activity with the
particles. (Figure 1C; Table I).
We hypothesized that the lack of entrapped hCE1 during PEI-mediated particle creation was
caused by either the rapid particle formation or catalyst size. That hypothesis was tested by
creating beads using different ratios of lysozyme and PEI in the presence of the same
amount of hCE1 (80% lysozyme:20% PEI, 50% lysozyme:50% PEI, and 20% lysozyme:
80% PEI). It was determined that increasing the amount of lysozme relative to PEI improved
the encapsulation of hCE1, but that no silica particles formed in the presence of PEI
exhibited higher levels of entrapped hCE1 activity than those formed without PEI (Figures
1D–F, Table I). We also concluded that hCE1 alone could not facilitate the precipitation of
silica particles without either lysozyme or the R5 peptide (data not shown). The reaction was
cooled to 4°C to see if the silica condensation could be slowed in the presence of PEI. The
reaction appeared to occur just as fast and no hCE1 was incorporated into the particles (data
not shown). Thus, we conclude that macromolecular catalysts as small as the R5 peptide and
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as large as hen egg white lysozyme are capable of generating silica nanoparticles that entrap
active hCE1.
Electron Microscopy of hCE1 Nanoparticles
We employed scanning electron microscopy (SEM) and transmission electron microscopy
(TEM) to examine the size and morphology of silica particles produced in the presence of
hCE1. Silica hCE1 particles using lysozyme as the catalyst were larger than the particles
obtained using either R5 or PEI as catalysts. Lysozyme-catalyzed particles were 0.8–1 μm
in diameter and appeared to fuse to form large aggregates on the order of ~ 2 μm (Figure
2A). In contrast, silica particles obtained in the presence of hCE1 using R5 and PEI as
catalysts formed individual particles 0.3–0.8 μm in diameter and an aggregate size of ~ 1
μm (Figure 2B and C). Dynamic light scattering (DLS) performed on the lysozyme
catalyzed silica particles confirmed the sizes measured from SEM analysis (data not shown).
The silica particles formed using the combinations of lysozyme and PEI were smaller (~ 0.5
μm) and appear monodisperse as compared to the particles using only lysozyme or PEI as
catalysts (Figure 2 D, E, F). Increasing amounts of PEI in the reaction lead to the formation
of smaller particles and smaller aggregate size.
TEM images corroborated the SEM data (Figure 3 A, B). For example, particles obtained in
the presence of lysozyme were larger in size compared to that of the PEI-catalyzed silica
particles. Further, the TEM images revealed that the lysozyme-catalyzed silica particles
exhibited a smoother surface than that of the PEI-catalyzed particles. In contrast, the
particles obtained using ratios of lysozyme and PEI as catalysts, appeared to have rougher
surface features similar to that seen for the PEI catalyzed particles. This was presumably due
to the presence of PEI on the particle surface (Figure 3 C, D and E).
Solution Detection Studies of Pesticides with hCE1 Nanoparticles
We examined whether silica nanoparticles containing active hCE1 could function in a
column chromatography format. Biosilica particles formed with lysozyme and hCE1 (see
Figures 1A, 2A) were packed using buffer flowed into a stainless steel microbore column (2
cm × 2 mm) with 0.5 μm frits controlled by a New Era single syringe pump (New Era Pump
Systems, Wantagh, NY). Particles catalyzed with lysozyme in the presence of hCE1 were
chosen because they were cost-effective and displayed robust entrapment efficiency and
enzyme activity. After extensive washing of the column, 5 mM pNPB was applied to the
column and para-nitrophenol formation was observed, indicating that hCE1 retains its
enzyme activity in the silica particles packed within the column (Figure 4). No hCE1
activity was detected in the solutions used to wash the column, supporting the conclusion
that the enzyme remained encapsulated in the column particles.
To determine whether columns containing hCE1 biosilica nanoparticles were capable of
detecting organophosphate pesticides, we added the pesticides and monitored substrate
conversion to para-nitrophenol. Columns were operated in the manner described above, and
equilibrated such that a stable amount of para-nitrophenol product was being formed over
time (e.g. 10 μmol/min.). At that point, 1 mM diethyl para-nitrophenyl phosphate
(paraoxon) was applied to a column, which produced a dramatic drop in enzyme activity
resulting in decreased substrate conversion (Figure 4A). Detection of the presence of this
hCE1 inhibitor occurs rapidly, likely due to the small column volume of 16.2 μL. hCE1
remains permanently inhibited by paraoxon even 50 minutes (~70 column volumes) after
this inhibitor is removed from the substrate-containing solution applied to the column
(Figure 4A). In a second study, dimethyl-para-nitrophenylphosphate (DMPNPP) was
applied to a column instead of paraoxon. In this case, detection of the hCE1 inhibitor was
rapid, but once the inhibitor was removed, hCE1 activity returned over time (Figure 4B).
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Paraoxon inhibits hCE1 activity 3-fold more robustly in solution than DMPNPP (with
bimolecular rates of inhibition [ki] values of 9.1 ± 0.5 × 106 min−1M−1 and 2.9 ± 0.3 × 106
min−1M−1, respectively)18. Taken together, these results indicate that OP pesticides can be
detected using hCE1 biosilica nanoparticles within a column chromatography format.
DISCUSSION
Silica nanoparticles have the potential to generate a range of platforms for biodetection. We
have shown that hCE1 can be effectively encapsulated into silica nanoparticles catalyzed by
lysozyme, and that these particles maintain overall enzyme activity comparable to hCE1 in
solution. In our studies, however, lysozyme-encapsulated hCE1 exhibited a slightly reduced
initial rate of product formation, although activity reached that of free hCE1 over time. We
hypothesize that this effect is caused by impeded substrate access to the active site of the
enzyme in the silica matrix. We also found that hCE1 is more efficiently incorporated into
silica nanoparticles using lysozyme as a catalyst in comparison to PEI catalyzed silica
particles. Similar results have been observed with other enzymes during encapsulation5.
We focused on three catalysts – lysozyme, the R5 peptide, and PEI – which have been
demonstrated to be successful in previous studies with other target enzymes22,23,24. Based
on our results, we hypothesize that the lack of entrapped hCE1 during PEI-mediated particle
creation was caused by the rapid particle formation and the small size of PEI. For example,
when lysozyme was used as a catalyst, the reaction proceeded slowly taking approximately
2 minutes until particles can be visualized in solution; in contrast, when PEI was employed,
the particles formed immediately. This observation, combined with the smaller sized PEI-
catalyzed particles relative to those created with lysozyme suggested that PEI-generated
silica matrixes excluded hCE1 under the reaction conditions employed. The lysozyme-
catalyzed particles underwent more complete condensation similar to that seen for pure sol-
gel silica reactions with other enzymes25.
Finally, we demonstrated that silica nanoparticles containing hCE1 are able to detect OP
pesticides in a column chromatography format. The drop in hCE1 activity correlated with
the strength of the inhibitor employed; for example, paraoxon, a more potent hCE1 inhibitor,
did not allow enzyme activity to recover during the time course of the study. It is possible
that such an apparatus could be employed in the detection of OP pesticides or chemical
weapons agents using silica nanoparticles containing hCE1. Both liquid- and gas-based
detection have already been reported involving other enzymes, including the
cholinesterases2. Our data indicate that another member of the serine hydrolase family of
enzymes may also be employed for this or related technologies.
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Activity assays measuring the formation of para-nitrophenol at 410 nm. Silica particles were
formed using the respective catalysts and the absorbance was measured over time. Activity
was measured for the silica particles and the supernatant from the reaction, then compared to
hCE1 in solution. All data points had an N = 3 and S.E. is reported.
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SEM images of the silica particles containing hCE1 at two magnifications. The samples
were sputtered with Au-Pd conductive coating prior to analyses.
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TEM images of the hCE1 encapsulated silica particles at two magnifications. Particles were
air dried on a carbon stabilized copper grid prior to imaging.
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Microbore columns packed with lysozyme catalyzed silica particles containing hCE1 at a
concentration of 8.065 × 10−2 nmol used to detect pesticides. The columns were equilibrated
at 25° C to maximum activity with 5 mM substrate before 1 mM pesticide was applied (grey
box). The eluent from the column was collected and measured in triplicate at the respective
time points. All data points had an N = 3 and S.E. is reported.
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Table I
hCE1 rate of pNBP hydrolysis in solution compared to silica particles created with different catalysts.
Sample hCE1 Activity (moles of nitrophenol/second) R2
hCE1 in solution 3.42 × 10−7 0.99
Lysozyme 2.74 × 10−7 0.99
R5 2.90 × 10−7 0.99
PEI NA
80% Lysozyme, 20% PEI 2.52 × 10−7 0.99
50% Lysozyme, 50% PEI 3.03 × 10−8 0.99
20% Lysozyme, 80% PEI NA
Lysozyme washed with 1% Tween 20 1.50 × 10−7 0.99
hCE1 Solution with 1% Tween 20 6.04 × 10−8 0.99
NA: not applicable, no enzyme activity contained in the particles.
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Table II
Kinetic parameters for the metabolism of pNPB by hCE1 in solution and in lysozyme catalyzed silica
particles.
Kinetic Parameters hCE1 in Solution hCE1 in Lysozyme Silica
Km (mM) 3.30 ± 0.44 10.13 ± 0.85
Vmax (μmole/min/mg) 97.71 ± 4.84 189.72 ± 7.41
Curve Fit (r2) 0.99 0.99
kcat/Km (s−1 M−1) 6.09 × 104 3.85 × 104
N=3, S.E. for Km and Vmax values
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